In the world of mobile apps, things change quickly, and it stands to reason that, as mobile phone makers added [...]
For US healthcare companies considering an acquisition of a medical device or in vitro diagnostics company in the EU or [...]
FDA’s Guidance on Real-World Evidence for Medical Devices: Great for Class III Registry Participants, But What About the Rest of MedTech?
On August 31, 2017, the FDA issued a final version of a guidance entitled, “Use of Real-World Evidence to Support [...]
CMS recently released Open Payments data submitted by applicable pharmaceutical and medical device manufacturers for calendar year 2015, and it [...]
In March 2016, two global life sciences companies agreed to pay hundreds millions of dollars in fines to resolve claims [...]
The Open Payments reporting period for payments made in calendar year 2015 by applicable pharmaceutical, device, biological, and medical supply [...]